📊 Score Breakdown
Offering Ability
90
Cash Runway
0
Float Risk
62
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
26%
🔄 Reverse Split
30%
• 50-day avg $1.49 approaching $1 threshold
📉 Score Deterioration
25%
• Score increased 10 points recently (worsening)
💰 Capital Raise
20%
• Active shelf registration ($500M, 616% of market cap)
💹 Market Data
Market Cap$81.15M
Shares Outstanding57.31M
Float16.98M
Cash$2.31M
Debt$27.46M
Short InterestN/A
🏛 Institutional Holdings
1 institutional holders · 143 shares
#1
Your Advocates Ltd., LLP
143 shares
📉 Short Interest
Short Interest53.8K
Days to Cover7.0
% of Float0.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 30, 2025
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
6-K
8K EVENT
Mar 19, 2026
EFFECT
EFFECT
Mar 11, 2026
F-3/A
SHELF
Mar 04, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ZKIN
📊 ZKIN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ZKIN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.